Shah Sara Mehmood Birchall, Barron Anthony, Klinger Corinna, Wright John S F
LSE Health, Department of Social Policy, London School of Economics and Political Science, Houghton Street, London WC2A 2AE, United Kingdom.
LSE Health, Department of Social Policy, London School of Economics and Political Science, Houghton Street, London WC2A 2AE, United Kingdom.
Health Policy. 2014 May;116(1):27-36. doi: 10.1016/j.healthpol.2014.02.014. Epub 2014 Mar 2.
Independent regulatory agencies (IRAs) for Health Technology Assessment (HTA) are a key means by which national governments have responded to the challenge of ensuring equitable public access to a new range of medicines and treatment options within the context of limited national budgets for healthcare. In this paper, we apply a regulatory governance frame to the study of the Swedish process for HTA. Based on qualitative interviews with key institutional stakeholders, we suggest that the major challenge for Swedish IRAs for HTA is successfully communicating nationally produced research outputs to the regional authorities responsible for the delivery of health services. We conclude that a regulatory governance approach to the analysis of national processes for HTA has the capacity to draw attention to a new range of challenges and issues which have direct relevance to improving the conduct of HTA within national regulatory spaces.
卫生技术评估（HTA）的独立监管机构（IRA）是各国政府应对挑战的关键手段，即在国家医疗保健预算有限的情况下，确保公众公平获得一系列新的药品和治疗选择。在本文中，我们将监管治理框架应用于瑞典HTA流程的研究。基于对关键机构利益相关者的定性访谈，我们认为瑞典HTA的IRA面临的主要挑战是将国内产生的研究成果成功传达给负责提供卫生服务的地区当局。我们得出结论，对国家HTA流程进行分析的监管治理方法有能力引起人们对一系列新挑战和问题的关注，这些挑战和问题与改善国家监管范围内的HTA实施直接相关。
